
|Articles|February 6, 2015
- Gastrointestinal Cancers (Issue 4)
- Volume 4
- Issue 1
Chemotherapy Treatment in Gastric Cancer
Author(s)Eric Van Cutsem, MD, PhD
Eric Van Cutsem, MD, PhD, discusses the challenges of using chemotherapy to treat patients with gastric cancer.
Eric Van Cutsem, MD, PhD, at University Hospitals Gasthuisberg/Leuven in Leuven, Belgium, discusses the challenges of using chemotherapy to treat patients with gastric cancer.
Clinical Pearls:
- Using trastuzumab or other anti-HER2 agents when treating patients with gastric cancer does not eliminate the need to use chemotherapy.
- Patients with gastric cancer are often in poor health to begin with and have low tolerance levels and fast occurrances of resistance after undergoing chemotherapy.
- There is room for growth and improvement in chemotherapy in order to determine if the treatments can contain less toxicities, which remains a challenge for patients in regards to their overall means of survival.
Articles in this issue
almost 11 years ago
Expert Investigators Discuss Emerging Therapies for GI Cancersalmost 11 years ago
Predictors of Toxicity in Colon Cancer Treatment Identifiedalmost 11 years ago
Many Biliary Tract Cancers Harbor Actionable Mutationsalmost 11 years ago
Safety of Regorafenib Confirmed in Patients With mCRC and High PFSalmost 11 years ago
Pembrolizumab in Advanced Gastric Cancer Treatmentalmost 11 years ago
Onartuzumab for Gastroesophageal Adenocarcinomaalmost 11 years ago
FOLFOXIRI plus Bevacizumab for Metastatic Colorectal Cancer






































